Nature, Published online: 27 October 2026; doi:10.1038/d41586-026-03482-5
Despite setbacks, pharma companies are betting big on psychedelic drugs to treat mental-health conditions. Plus, longevity researchers are turning their attention to pets and how to keep tabs on the tools in your lab.AI & ML
Daily briefing: The future of psychedelics
Nature News0 views
Source：https://www.nature.com/articles/d41586-026-03482-5
PreviousDaily briefing: The big push to personalize psychiatryNextMan granted first-of-its-kind religious exemption against mandatory AI use at work — Humanist argues that offloading his thinking to LLMs violates his beliefs, Title VII accommodation protects employe
Related posts
Cilium 1.20.0 Requires BTF Flag in Linux Kernel, Raspberry Pi OS Kernel Incompatible Without It
0dev.to
YC Labs and Olam Labs ran 50 AI agents in a Minecraft civilization experiment
0dev.to
Lavoro su piattaforma e algoritmi: cosa cambia con la direttiva europea per chi progetta il software
0dev.to
LifeVal Benchmark Targets Everyday Personal Assistant Tasks Shaped by ChatGPT User Feedback
0dev.to
Oracle files to sell $20B in new stock, bonds to finance AI buildout
0Hacker News
7.9% to 48.1%: LLM rewrote Qwen weights, no training
0dev.to